Denis Chem Lab Ltd

AGM Details

• 45th AGM scheduled for 25 September 2026 at 12:00 IST via VC/OAVM.

Ordinary Business

• Adopt Audited Financial Statements for year ended 31 March 2026.
• Declare final dividend per equity share for FY 2025-26.
• Re-appoint director retiring by rotation.

Special Business

• Cost Auditors remuneration and appointment for 2026-27.
• Secretarial Auditors appointment for five consecutive years (FY 2026-27 to 2030-31).
• Managing Director re-appointment for three-year term with board-approved remuneration.

Dividend

• Final dividend proposal for FY ended March 2026; per-share amount to be announced if approved.

Directors & MD Changes

• Managing Director re-appointment for three-year term from Aug 2026.
• Director retiring by rotation proposed for re-appointment.

Auditors

• Statutory Auditors: continuing without change.
• Cost Auditor to be appointed for FY 2026-27; remuneration as approved.

Related Party Transactions

• Related party transactions occurred in ordinary course; not material.
• Includes rent, procurements, and remuneration to related parties.

Other Material Approvals

• CSR activities and CSR policy; CSR expenditure disclosed; CSR committee functioning.

Financial highlights

• Revenue from operations: ₹4,399.67 lakh in Q1 FY27 (Standalone, unaudited).
• Total income: ₹4,444.67 lakh; YoY growth ~2%.
• Expenses: ₹4,180.30 lakh; materials ₹2,383.17; employee ₹419.35; depreciation ₹152.99.
• Profit before tax: ₹264.37 lakh; tax ₹59.85 lakh; PAT ₹204.52 lakh.
• EPS (basic/diluted): ₹1.47 for Q1 FY27.
• Single segment: transfusion solutions in bottles.
• PAT declined ~17% YoY to ₹204.52 lakh.

Meeting Details

• 13 August 2026 board meeting to consider unaudited quarterly results (quarter ended 30 June 2026).
• Time and venue not disclosed.

Key Agenda Items

• Approve unaudited financial results for the quarter ended 30 June 2026.

Other Notes

• Trading window remains closed for designated persons until 48 hours after results declaration.

Transaction summary

• Target Company: DENIS CHEM LAB LIMITED.
• Disclosing Party: VS HOLDING BV (Seller); not promoter group.
• Transaction Type: Acquisition of voting rights in DENIS CHEM LAB LIMITED.
• Pre-Transaction Holding: 2,877,774 shares, 20.74%.
• Transaction Details: 285,845 shares acquired (2.06%); open market; July 2026.
• Post-Transaction Holding: 2,591,929 shares, 18.68%.
• Equity capital before/after: Rs. 1,38,76,6680 comprising 1,38,76,668 equity shares.
• Date(s) of Transaction: Multiple transactions during July 2026 up to 30 July 2026.
• Mode: Open Market.
• Total diluted share capital after: 1,38,76,6680.

Managing Director Reappointment

• Dr. Himanshu C. Patel reappointed as MD for 3 years from 1 August 2026, following board recommendation.
• Profile: BE, MS, PhD; 4+ decades in medical/pharma; not debarred; related to Anar H. Patel and Dinesh B. Patel.

Key Decisions

• AGM 45th to be held 25 September 2026 via VC/OAVM.
• Record date fixed at 18 September 2026 for final dividend, if declared.
• Remote e-voting opens 22 September 2026 09:00 IST and closes 24 September 2026 17:00.
• E-voting entitlement cut-off is 18 September 2026; AGM e-voting ends 15 minutes after conclusion.
• Secretarial Auditor appointed: Kashyap R. Mehta & Partners for five years, FY2026-27 to FY2030-31.
• MD reappointment: Dr. Himanshu C. Patel as MD for 3 years from 1 Aug 2026, subject to AGM.
• Dividend payment will be made on or after 25 September 2026 if final dividend is declared.

Dematerialisation status

• Dematerialisation requests processed; securities received were confirmed (accepted/rejected) to depositories.
• Securities dematerialised are listed on the stock exchanges where existing securities are listed.
• Physical certificates received for dematerialisation were mutilated and cancelled after verification.
• Depository name substituted as registered owner in records within prescribed timelines.